Subgroup | Patients, No. | OS | PFS | ||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
TNM stage | Â | Â | Â | Â | Â |
 II | 65 | Reference |  | Reference |  |
 III | 42 | 1.48 (1.04–2.47) | 0.13 | 1.42 (1.06–2.34) | 0.17 |
 IV | 19 | 2.10 (1.09–4.04) | < 0.05 | 1.98 (1.02–3.84) | < 0.05 |
S2 |  |  | < 0.001 |  | < 0.05 |
 Over-expression | 79 | Reference |  | Reference |  |
 Under-expression | 47 | 2.26 (1.40–3.67) |  | 2.23 (1.36–3.65) |  |
S3 |  |  | < 0.05 |  | < 0.05 |
 Over-expression | 92 | Reference |  | Reference |  |
 Under-expression | 34 | 0.48 (0.29–0.79) |  | 0.55 (0.33–0.90) |  |